Colorectal cancer (Q93917269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9950460%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

review article

1 reference

title

Colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9950460%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

1 reference

R Midgley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9950460%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

D Kerr

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9950460%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9950460%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9950460%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

volume

353

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9950460%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

issue

9150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9950460%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

page(s)

391-399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9950460%20AND%20SRC:MED&resulttype=core&format=json

Genetic alterations during colorectal-tumor development

11 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Novel germline APC gene mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Mutations of two PMS homologues in hereditary nonpolyposis colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Clues to the pathogenesis of familial colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

1 reference

7 January 2021

Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Randomised study of screening for colorectal cancer with faecal-occult-blood test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Screening sigmoidoscopy and colorectal cancer mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Mesorectal excision for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

The outcome following sphincter-saving resection and abdominoperineal resection for low rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Prognostic factors in colorectal carcinoma treated by preoperative radiotherapy and immediate surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Rectal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907127-X

7 January 2021

10.1016/S0140-6736(98)07127-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9950460%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

1 reference